Dechert advised Royalty Pharma plc on IP-related matters on the deal. Goodwin Procter LLP advised Royalty Pharma plc, while Mintz advised the Cystic Fibrosis Foundation on…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
